United States · Platforms & data · Stocktwits

Sellas To Present SLS009 Data At American Society of Hematology – Initial Results Of Therapy In Newly Diagnosed AML Patients Expected In Q4

Published by Stocktwits · United States 9 h ago

Sellas Life Sciences (SLS) was in the spotlight on Wednesday after the biotech firm said it will present Phase 2 results for its experimental blood cancer treatment SLS009 at the…

Read the full article on Stocktwits Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stocktwits.com)

Also worth reading

The Motley Fool

Avis (CAR) Q3 2026 Earnings Call Transcript

MarketWatch

Hospital stocks rally while drugmakers brace for scrutiny. Here’s what the Democratic wave means for healthcare.

CNBC

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

Investing.com

Curtiss-Wright stock hits 52-week low at 453.32 USD

Benzinga

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

TipRanks